Utility Therapeutics wins FDA nod for UTI antibiotic that has been on the market in Europe for 40-plus years
Fierce Pharma
APRIL 25, 2024
It’s an odd set of circumstances and a dose of foresight by Utility Therapeutics that bring Pivya (pivmecillinam) to the market in the United States in the therapy’s golden years. And the endorsement has come for an oral antibiotic that has been available in Europe for more than 40 years.
Let's personalize your content